Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Virtually, of course. So take a look around.
4% of total U.S. AIDS philanthropy directly addresses African Americans. Plus: Meet the top five funders helping BIPOC communities.
Join a week of activities leading up to the virtual march in Washington, DC, on Saturday, October 3.
In a large study that included a substantial cohort of meth users, the drug was the dominant risk factor for testing positive for HIV.
Cristina Herrera provides support for the Latinx transgender community.
The results of the 2020 election will have many long-term consequences. There isn’t an issue that won’t be greatly affected, including HIV.
AIDS United explains the importance of three Supreme Court decisions, which the group views as two wins and a loss.
A recent study analyzed smoking’s ties to substance use and mental, psychological and general health in sexual minority men and trans women.
A similar training program, ESCALATE, will teach communities to recognize and fight HIV stigma.
The REPRIEVE study, which is primarily looking at a statin’s effect on cardiovascular disease, is shedding light on many other mysteries.
Cabotegravir injections given every eight weeks as PrEP are even more effective than daily Truvada.
Supreme Court decisions and a Trump pronouncement on health care affect HIV efforts
Researchers ran a Gallup poll of HIV-negative transgender people to assess their risk of HIV, familiarity with PrEP and other factors.
We asked participants and presenters at the #AIDS2020Virtual what was compelling to them about the gathering. Here are their responses.
The study’s authors saw no evidence that the participants increased their sexual risk taking during the 96-week trial.
The placebo-controlled trial compared injections of cabotegravir given every eight weeks versus daily Truvada as PrEP.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.